ValueQ3, 24Q4, 24TTMCash from investing activities25.41 M27.24 M350.44 MCash from financing activities103.86 M254.57 M969.59 MFree cash flow288.84 M332.36 M875.84 M
Exelixis Inc
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.